Nonaka myopathy

From WikiMD's Wellness Encyclopedia


=Nonaka Myopathy = Nonaka Myopathy, also known as GNE myopathy or hereditary inclusion body myopathy (HIBM), is a rare genetic disorder characterized by progressive muscle weakness. It is a type of distal myopathy, primarily affecting the muscles of the lower limbs.

Clinical Features[edit | edit source]

Nonaka Myopathy typically presents in early adulthood, often between the ages of 20 and 40. The initial symptoms usually include weakness in the anterior compartment of the lower legs, leading to foot drop and difficulty with dorsiflexion. As the disease progresses, muscle weakness may extend to the upper limbs and other muscle groups.

Symptoms[edit | edit source]

  • Progressive muscle weakness
  • Foot drop
  • Difficulty walking
  • Muscle atrophy

Genetic Basis[edit | edit source]

Nonaka Myopathy is caused by mutations in the GNE gene, which encodes the enzyme UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase. This enzyme is crucial for the biosynthesis of sialic acid, an important component of glycoproteins and glycolipids.

Inheritance Pattern[edit | edit source]

The condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the disease.

Diagnosis[edit | edit source]

Diagnosis of Nonaka Myopathy is based on clinical evaluation, family history, and genetic testing. Muscle biopsy may show characteristic features such as rimmed vacuoles and inclusion bodies.

Diagnostic Tests[edit | edit source]

  • Genetic testing for GNE mutations
  • Muscle biopsy
  • Electromyography (EMG)

Treatment[edit | edit source]

Currently, there is no cure for Nonaka Myopathy. Treatment focuses on managing symptoms and improving quality of life. Physical therapy and occupational therapy can help maintain muscle function and mobility.

Management Strategies[edit | edit source]

  • Physical therapy
  • Orthotic devices for foot drop
  • Occupational therapy

Research and Future Directions[edit | edit source]

Research is ongoing to better understand the pathophysiology of Nonaka Myopathy and to develop potential therapies. Gene therapy and enzyme replacement therapy are areas of active investigation.

See Also[edit | edit source]

,

 Hereditary inclusion body myopathy: A review, 
 Journal of Neurology, 
 2000, 
 Vol. 247(Issue: 9), 
 pp. 625-632,

,

 Muscle Diseases: Pathology and Genetics, 
  
 Springer, 
 2015,

NIH genetic and rare disease info[edit source]

Nonaka myopathy is a rare disease.

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD